Biodegradable polylactic acid nanocapsules containing ciprofloxacin: Preparation and characterization

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 27, Issue 3, 1999, Pages 263-278

  Yu, W P ^a   Wong, J P ^b   Chang, T M S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Biodegradable; Ciprofloxacin; Drug release; Nanocapsules; Polylactic acid

Indexed keywords

BIODEGRADATION; ENCAPSULATION; NANOSTRUCTURED MATERIALS; ORGANIC POLYMERS;

CIPROFLOXACIN; POLYLACTIC ACID;

DRUG PRODUCTS;

ANTIINFECTIVE AGENT; BUFFER; CIPROFLOXACIN; NANOCAPSULE; PHOSPHATE; POLYLACTIC ACID;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; MACROPHAGE;

EID: 0033006197     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199909117699     Document Type: Article

References (14)

1. Barratt, G., Puisieux, F., Yu, W.P., Foucher, C., Fessi, H., Devissaguet, J.P. (1994) Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. Int. J. Immunopharm. 16: 457-461
2. Brasseur, E.L., Couvreur P., Kanta, B., Deckers-Passau, L., Roland, M., Deckers, C. & Speiser, P. (1980), Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. Eur. J. Cancer 16, 1441-1445
3. Chang TMS (1976), Biodegradable microcapsules containing enzymes, hormones, vaccines and other biologicals. Journal of Bioengineering, 1,25
4. Couvreur P., Kante, B., Roland M. and Speiser, P. (1982) Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J. Pharm. Sci., 71, 790-792
5. Crump, B., Wise, R. and Dent, J. (1983), Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy, 26(5): 784
6. Hoffken, G., Lode, H., Prinzing, C., Borner, K., and Koeppe, P. (1985), Pharmacokinetics of giprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy, 27(3): 375
7. Losa, C., Calvo, P., Castro, E., Vila-Jato, L., and Alonso, M., (1991) Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J. Pharm. Pharmacol. 43, 548-552
8. Martinez, B., Lairion, F., Pena, M.B., Di Rocco, P. and Nacucchio, M.C. (1997), In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres, J. Microencapsulation 14(2): 155-161
9. Morin, C., Fessi, H., Devissaguet, J.P., Puisieux, F., Barratt, G., (1994) Factors influencing macrophage activation by muramyl peptides: inhibition oh NO synthase activity by high levels of NO. Biochimica et Biophysica Acta. 1224, 427 -432
10. Owusu-Ababio (1995), Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model, J. Med. Microbiol. 43: 368-376
11. Wong, J.P., Cherwonogrodzky, J.W., Di Ninno, V.L., Delacruz, R. and Saravolac, E.G. (1995), Liposome-encapsulated ciprofloxacin for the prevention and treatment of infections diseases caused by intracellar pathogens, In: P.N. Shek (Ed.) Liposomes in Biomedical Applications. Harwood Acad. Press, Amsterdam, Holland. pp 105-134
12. Yu, W.P., Foucher, C., Barratt, G., Fessi, H., Devissaguet, J.P. And Puisieux, F. (1992) Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. 6ème Congrès International de Technologie Pharmaceutique, APGI, Paris, III, 83-92
13. YU WP, J. WONG & TMS CHANG (1998) Preparation and characterization of polylactic acid microcapsules containing ciprofloxacin for controlled release J. Microencapsulation. 15:515-523
14. Zimmer, A., Mutshler, E., Lambrecht, G., Mayer, D. and Kreuter, J., (1994) Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle delivery system. Pharm. Res, 11(10), 1435-1442